Evidence map›Paper›PMID 37726269›Full record

ArticleNature communications2023

Identification and characterization of endo-α-, exo-α-, and exo-β-D-arabinofuranosidases degrading lipoarabinomannan and arabinogalactan of mycobacteria.

Michiko Shimokawa, Akihiro Ishiwata, Toma Kashima, Chiho Nakashima, Jiaman Li, Riku Fukushima, Naomi Sawai, Miku Nakamori, Yuuki Tanaka, Azusa Kudo and 11 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 1 country.

Michiko Shimokawa *Faculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Akihiro Ishiwata *Cluster for Pioneering Research, RIKEN, Saitama, 351-0198, Japan.ORCID http://orcid.org/0000-0002-5542-2214
Toma Kashima *Department of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.
Chiho NakashimaDepartment of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.
Jiaman LiDepartment of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.
Riku FukushimaDepartment of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.
Naomi SawaiFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Miku NakamoriFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Yuuki TanakaFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Azusa KudoFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Sae MorikamiFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Nao IwanagaFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Genki AkaiDepartment of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan.
Nobutaka ShimizuPhoton Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki, 305-0801, Japan.ORCID http://orcid.org/0000-0002-3636-1663
Takatoshi ArakawaFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, 278-8510, Japan.ORCID http://orcid.org/0000-0001-6496-5440
Chihaya YamadaSchool of Agriculture, Meiji University, Kawasaki, Kanagawa, 214-8571, Japan.
Kanefumi KitaharaFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan.
Katsunori TanakaCluster for Pioneering Research, RIKEN, Saitama, 351-0198, Japan.
Yukishige ItoCluster for Pioneering Research, RIKEN, Saitama, 351-0198, Japan.
Shinya FushinobuDepartment of Biotechnology, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8657, Japan. asfushi@mail.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-1346-6435
Kiyotaka FujitaFaculty of Agriculture, Kagoshima University, Kagoshima, 890-0065, Japan. k4022897@kadai.jp.ORCID http://orcid.org/0000-0002-3780-3750
Kagoshima University · JPThe University of Tokyo · JPPioneer (Japan) · JPHigh Energy Accelerator Research Organization · JPMeiji University · JPTokyo Institute of Technology · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cell walls of pathogenic and acidophilic bacteria, such as Mycobacterium tuberculosis and Mycobacterium leprae, contain lipoarabinomannan and arabinogalactan. These components are composed of D-arabinose, the enantiomer of the typical L-arabinose found in plants. The unique glycan structures of mycobacteria contribute to their ability to evade mammalian immune responses. In this study, we identified four enzymes (two GH183 endo-D-arabinanases, GH172 exo-α-D-arabinofuranosidase, and GH116 exo-β-D-arabinofuranosidase) from Microbacterium arabinogalactanolyticum. These enzymes completely degraded the complex D-arabinan core structure of lipoarabinomannan and arabinogalactan in a concerted manner. Furthermore, through biochemical characterization using synthetic substrates and X-ray crystallography, we elucidated the mechanisms of substrate recognition and anomer-retaining hydrolysis for the α- and β-D-arabinofuranosidic bonds in both endo- and exo-mode reactions. The discovery of these D-arabinan-degrading enzymes, along with the understanding of their structural basis for substrate specificity, provides valuable resources for investigating the intricate glycan architecture of mycobacterial cell wall polysaccharides and their contribution to pathogenicity.

Indexed as

EndometriosisMycobacterium tuberculosisAnimalsFemaleGalactansHumansLipopolysaccharidesMammalsarabinogalactanGalactanslipoarabinomannanLipopolysaccharides

Identifiers

PMID37726269
PMCPMC10509167
OpenAlexW4386864830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.